Clinical trial using a new malaria vaccine

GMO Register No: G0451-01

Reference No: B/IE/11/451(a) & B/IE/11/451(b)


On 27 September 2011, the Environmental Protection Agency (EPA) granted consent, subject to specified conditions, to Professor Samuel McConkey, Royal College of Surgeons in Ireland, to carry out a clinical trial on patients to assess the safety and immunogenicity of a new malaria vaccine, using two genetically modified micro-organisms, at Beaumont Hospital in Dublin, from September 2011 to December 2012.

Relevant Documentation

Inspector’s Report
Consent Conditions
GMO Register G0451-01
Final Report

GMO Register

The trial was assigned GMO Register No G0451-01. The Register provides significant details about the trial.


Any person or organisation proposing to carry out a deliberate release of a genetically modified organism (GMO) for purposes other than placing on the market (performance of field trials) must comply with the legislative requirements set out under Part II of the GMO (Deliberate Release) Regulations S.I. No 500 of 2003.